Dynepo

Dynepo is a form of pharmaceutical erythropoietin (EPO) under development as a pharmaceutical product by Shire Pharmaceuticals. The first development steps were performed by HMR and Aventis. Aventis obtained the license in Europe in 2002. The company expects to launch the product in Europe in 2006, although patents held by the American biotechnology company Amgen, Inc. may preclude its sale in the United States.

EPO is a natural human hormone that stimulates formation of red blood cells. It is made via recombinant DNA technology. Pharmaceutical EPO is used to treat anemia, but has also been used by doping athletes to improve their aerobic performance and stamina.

Unlike existing forms of pharmaceutical EPO manufactured in cultured animal cells, Dynepo is to be made in cultured human cells. It is therefore expected to have an authentic human form of sialic acid and other oligosaccharide residues. This characteristic may make it a longer-acting product than existing brands, but clinical data have not yet been made public. It should also make Dynepo undetectable in the existing urine test for EPO used to detect doping by athletes.

On July 1, 2009, professional cycling team announced that Thomas Dekker was tested positive for dynepo on a test taken on December 24, 2007, while Dekker was riding for 2007.

References

Dynepo EPAR ^{(European Public Assessment Report)}, European Medicines Agency

• Need help finding a doctor or specialist anywhere in the world? WikiMD's DocFinder can help with millions of doctors!

This article is a stub. Help WikiMD grow by registering to expand it. Editing is available only to registered and verified users. About WikiMD: A comprehensive, free health & wellness encyclopedia.

Dynepo Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski